Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-25 @ 1:02 AM
Ignite Modification Date:
2025-12-25 @ 1:02 AM
NCT ID:
NCT00610493
Brief Title:
Bevacizumab and Temsirolimus in Patients With Advanced Malignancy
Official Title:
A Phase I Trial of Bevacizumab and Temsirolimus in Patients With Advanced Malignancy
Study:
NCT00610493
Protocol Section:
NCT00610493